Literature DB >> 32309895

Liposarcoma of oral cavity: Systematic review of cases reported to date and analysis of prognostic factors.

Flávia S C Pontes1, Lucas L de Souza1, Élida N C Vulcão1, Michelle C de Abreu1,2, Sarah N Menezes1, Diogo Rezende1,2, Hélder A R Pontes1,2.   

Abstract

The aim of this study was to integrate the available data published on Liposarcomas (LPSs) of the oral cavity into an analysis of its clinical features, treatment modalities, and prognostic factors. An electronic search was undertaken in January 2019. The eligibility criteria included publications that had enough clinical and histological information to confirm the diagnosis. Forty-five publications (104 LPSs) were included. The lesion was more prevalent in males from the fifth to seventh decades of life. Treatment (P = .03) and distant metastasis (P = .0001) were independently associated with survival. A lower possibility of recurrence was statistically associated with age (younger patients) (P = .03), tumor size (smaller than 2.8 cm) (P = .001), and treatment (radical surgery) (P = .04). LPS presents a good survival for patients after 5 years of follow-up (66.4%). Patients who were treated with conservative surgery and presented with distant metastasis showed poor prognosis.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  distant metastasis; liposarcoma; oral cavity; recurrence; survival

Mesh:

Year:  2020        PMID: 32309895     DOI: 10.1002/hed.26160

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  Inflammatory Variant of Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma of the Buccal Mucosa: An Overview and Case Report with a 10-Year Follow-Up.

Authors:  José Alcides Almeida de Arruda; Diego Antônio Costa Arantes; Lauren Frenzel Schuch; Lucas Guimarães Abreu; Bruno Augusto Benevenuto de Andrade; Mário José Romañach; Ricardo Alves Mesquita; Satiro Watanabe; José Carlos de Oliveira; Elismauro Francisco Mendonça
Journal:  Head Neck Pathol       Date:  2020-10-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.